Status:
COMPLETED
Preoperative Oral Pregabalin Effect on Inhalational Anesthetic Requirements ln Hysterectomy Under General Anesthesia
Lead Sponsor:
Nesrine El-Refai
Conditions:
Hysterectomy
Eligibility:
FEMALE
18-60 years
Phase:
PHASE3
Brief Summary
In this study the investigators hypothesized that preoperative pregabalin tablet (150 mg orally ) may be effective in reducing intraoperative isoflurane requirements needed to maintain intraoperative ...
Detailed Description
In this study the investigators hypothesized that preoperative pregabalin tablet (150 mg orally ) would be effective in reducing intraoperative isoflurane requirement needed to maintain intraoperative...
Eligibility Criteria
Inclusion
- Female patients, aged 18-60 year scheduled for elective abdominal hysterectomy surgery under general anaesthesia.
- American Society of Anaesthesiology (ASA) physical status I or II.
Exclusion
- American Society of Anaesthesiology (ASA) physical status ≥ III.
- Allergy or hypersensitivity to pregabalin.
- Patient on calcium channel blocker or anticonvulsant.
Key Trial Info
Start Date :
June 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03302208
Start Date
June 29 2017
End Date
September 20 2017
Last Update
January 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Zamalek, Egypt, 11586